Q&A

FAQs: Challenging Host Cell Protein Assays For Improved Risk Mitigation

Source: Cytiva
GettyImages-492098616-ELISA

Andrew Hamilton, PhD, Scientist, Imaging & Western Blotting, and Joe Hirano, PhD, Program Manager, Imaging & Western Blotting, answer top questions about challenging host cell protein assays. Topics covered include: alternate technology, coverage analysis, ELISA antibody, ELISA troubleshooting, ELISA validation, HCP, and regulatory requirements.

access the Q&A!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online

Please tell us more about you so that we can customize our newsletters to your specific interests:

What topics interest you? (Check all that apply.)

Cytiva